Helical apolipoproteins of high-density lipoprotein enhance phagocytosis by stabilizing ATP-binding cassette transporter A7

Journal of Lipid Research

Volumn 51, Issue 9, 2010, Pages 2591-2599

  Tanaka, Nobukiyo ^a   Abe Dohmae, Sumiko ^a   Iwamoto, Noriyuki ^a   Fitzgerald, Michael L ^b,c   Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LABORATORY FOR MOLECULAR MEDICINE   (United States)

Author keywords

ABCA1; ABCA7; apoA I; Cholesterol; HDL; Phagocytosis

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER A7; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CALPAIN; CYTOCHALASIN D; HIGH DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; EMBRYO; FIBROBLAST; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; QUANTITATIVE ANALYSIS; RNA INTERFERENCE;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; FIBROBLASTS; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; RNA, SMALL INTERFERING; STAPHYLOCOCCUS AUREUS;

EID: 77956826011     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M006049     Document Type: Article

References (42)

1. Kaminski, W. E., E. Orso, W. Diederich, J. Klucken, W. Drobnik, and G. Schmitz. 2000. Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem. Biophys. Res. Commun. 273: 532-538.
2. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
3. Francis, G. A., R. H. Knopp, and J. F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest. 96: 78-87.
4. Remaley, A. T., U. K. Schumacher, J. A. Stonik, B. D. Farsi, H. Nazih, and H. B. Brewer, Jr. 1997. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17: 1813-1821.
5. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
6. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
7. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J. C. Piette, J. F. Deleuze, H. B. Brewer, N. Duverger, P. Denefle, et al. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22: 352-355.
8. Abe-Dohmae, S., Y. Ikeda, M. Matsuo, M. Hayashi, K. Okuhira, K. Ueda, and S. Yokoyama. 2004. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J. Biol. Chem. 279: 604-611.
9. Wang, N., D. Lan, M. Gerbod-Giannone, P. Linsel-Nitschke, A. W. Jehle, W. Chen, L. O. Martinez, and A. R. Tall. 2003. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J. Biol. Chem. 278: 42906-42912.
10. Hayashi, M., S. Abe-Dohmae, M. Okazaki, K. Ueda, and S. Yokoyama. 2005. Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. J. Lipid Res. 46: 1703-1711.
11. Kim, W. S., M. L. Fitzgerald, K. Kang, K. Okuhira, S. A. Bell, J. J. Manning, S. L. Koehn, N. Lu, K. J. Moore, and M. W. Freeman. 2005. Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J. Biol. Chem. 280: 3989-3995.
12. Linsel-Nitschke, P., A. W. Jehle, J. Shan, G. Cao, D. Bacic, D. Lan, N. Wang, and A. R. Tall. 2005. Potential role of ABCA7 in cellular lipid efflux to apoA-I. J. Lipid Res. 46: 86-92.
13. Iwamoto, N., S. Abe-Dohmae, R. Sato, and S. Yokoyama. 2006. ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis. J. Lipid Res. 47: 1915-1927.
14. Jehle, A. W., S. J. Gardai, S. Li, P. Linsel-Nitschke, K. Morimoto, W. J. Janssen, R. W. Vandivier, N. Wang, S. Greenberg, B. M. Dale, et al. 2006. ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages. J. Cell Biol. 174: 547-556.
15. Williamson, P., and R. A. Schlegel. 2002. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim. Biophys. Acta. 1585: 53-63.
16. Hamon, Y., O. Chambenoit, and G. Chimini. 2002. ABCA1 and the engulfment of apoptotic cells. Biochim. Biophys. Acta. 1585: 64-71.
17. Reddien, P. W., and H. R. Horvitz. 2004. The engulfment process of programmed cell death in caenorhabditis elegans. Annu. Rev. Cell Dev. Biol. 20: 193-221.
18. Jouret, F., and O. Devuyst. 2009. CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflugers Arch. 457: 1227-1236.
19. Yokoyama, S., S. Tajima, and A. Yamamoto. 1982. The process of dissolving apolipoprotein A-I in an aqueous buffer. J. Biochem. 91: 1267-1272.
20. Yokoyama, S., S. Tajima, and A. Yamamoto. 1984. Association of apolipoprotein A-II with egg phosphatidylcholine unilamellar vesicles. J. Biochem. 96: 871-880.
21. Hu, W., S. Abe-Dohmae, M. Tsujita, N. Iwamoto, O. Ogikubo, T. Otsuka, Y. Kumon, and S. Yokoyama. 2008. Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo. J. Lipid Res. 49: 386-393.
22. McNeish, J., R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. de Wet, et al. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA. 97: 4245-4250.
23. von Boxberg, Y., R. Wutz, and U. Schwarz. 1990. Use of the biotinavidin system for labelling, isolation and characterization of neural cell-surface proteins. Eur. J. Biochem. 190: 249-256.
24. Lu, R., R. Arakawa, C. Ito-Osumi, N. Iwamoto, and S. Yokoyama. 2008. ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation. Arterioscler. Thromb. Vasc. Biol. 28: 1820-1824.
25. Abe-Dohmae, S., S. Suzuki, Y. Wada, H. Aburatani, D. E. Vance, and S. Yokoyama. 2000. Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry. 39: 11092-11099.
26. Arakawa, R., and S. Yokoyama. 2002. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277: 22426-22429.
27. Ikeda, Y., S. Abe-Dohmae, Y. Munehira, R. Aoki, S. Kawamoto, A. Furuya, K. Shitara, T. Amachi, N. Kioka, M. Matsuo, et al. 2003. Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release. Biochem. Biophys. Res. Commun. 311: 313-318.
28. Arakawa, R., M. Hayashi, A. T. Remaley, B. H. Brewer, Y. Yamauchi, and S. Yokoyama. 2004. Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides. J. Biol. Chem. 279: 6217-6220.
29. Wang, N., W. Chen, P. Linsel-Nitschke, L. O. Martinez, B. Agerholm-Larsen, D. L. Silver, and A. R. Tall. 2003. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111: 99-107.
30. Yokoyama, S. 2006. Assembly of high-density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 26: 20-27.
31. Venkateswaran, A., B. A. Laffitte, S. B. Joseph, P. A. Mak, D. C. Wilpitz, P. A. Edwards, and P. Tontonoz. 2000. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA. 97: 12097-12102.
32. Costet, P., Y. Luo, N. Wang, and A. R. Tall. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275: 28240-28245.
33. Bjorkhem, I., and U. Diczfalusy. 2002. Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thromb. Vasc. Biol. 22: 734-742.
34. Tamehiro, N., Y. Shigemoto-Mogami, T. Kakeya, K. Okuhira, K. Suzuki, R. Sato, T. Nagao, and T. Nishimaki-Mogami. 2007. Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status. J. Biol. Chem. 282: 21090-21099.
35. Fukushima, D., S. Yokoyama, F. J. Kezdy, and E. T. Kaiser. 1981. Binding of amphiphilic peptides to phospholipid/cholesterol unilamellar vesicles: a model for protein-cholesterol interaction. Proc. Natl. Acad. Sci. USA. 78: 2732-2736.
36. Okuhira, K., M. Tsujita, Y. Yamauchi, S. Abe-Dohmae, K. Kato, T. Handa, and S. Yokoyama. 2004. Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL. J. Lipid Res. 45: 645-652.
37. Li, Y., R. F. Schwabe, T. DeVries-Seimon, P. M. Yao, M. C. Gerbod-Giannone, A. R. Tall, R. J. Davis, R. Flavell, D. A. Brenner, and I. Tabas. 2005. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280: 21763-21772.
38. Li, Y., M. C. Gerbod-Giannone, H. Seitz, D. Cui, E. Thorp, A. R. Tall, G. K. Matsushima, and I. Tabas. 2006. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J. Biol. Chem. 281: 6707-6717.
39. Sun, Y., M. Ishibashi, T. Seimon, M. Lee, S. M. Sharma, K. A. Fitzgerald, A. O. Samokhin, Y. Wang, S. Sayers, M. Aikawa, et al. 2009. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ. Res. 104: 455-465.
40. Tanaka, A. R., Y. Ikeda, S. Abe-Dohmae, R. Arakawa, K. Sadanami, A. Kidera, S. Nakagawa, T. Nagase, R. Aoki, N. Kioka, et al. 2001. Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjogren's Syndrome. Biochem. Biophys. Res. Commun. 283: 1019-1025.
41. Toda, Y., R. Aoki, Y. Ikeda, Y. Azuma, N. Kioka, M. Matsuo, M. Sakamoto, S. Mori, M. Fukumoto, and K. Ueda. 2005. Detection of ABCA7-positive cells in salivary glands from patients with Sjogren's syndrome. Pathol. Int. 55: 639-643.
42. Harangi, M., W. E. Kaminski, M. Fleck, E. Orso, M. Zeher, E. Kiss, Z. Szekanecz, E. Zilahi, J. Marienhagen, C. Aslanidis, et al. 2005. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome. Eur. J. Immunol. 35: 305-317.